Medical researchers suggest that future vaccine dosages may be determined by genetic markers rather than race, potentially requiring different doses for different ethnic groups. There is a critical perspective offered that minority populations are often used as the "baseline" for testing new medical technologies before they are calibrated for wealthier populations. This practice is framed as a form of systemic racism within the pharmaceutical industry.